Insider Transactions in Q4 2021 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$300,000
$30.0 P/Share
|
|
Dec 22
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$70,000
$7.27 P/Share
|
|
Dec 22
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
15,338
-50.5%
|
$460,140
$30.0 P/Share
|
|
Dec 22
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
15,338
+21.67%
|
$107,366
$7.18 P/Share
|
|
Nov 18
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
300
-0.43%
|
$9,300
$31.36 P/Share
|
|
Nov 18
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+0.43%
|
$1,800
$6.55 P/Share
|
|
Nov 17
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,700
-5.06%
|
$118,400
$32.05 P/Share
|
|
Nov 17
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,700
+4.82%
|
$22,200
$6.55 P/Share
|
|
Nov 15
2021
|
Kyle Piskel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,837
+36.42%
|
-
|
|
Nov 10
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.79%
|
$165,000
$33.93 P/Share
|
|
Nov 10
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+15.82%
|
$35,000
$7.27 P/Share
|
|
Nov 09
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.79%
|
$180,000
$36.03 P/Share
|
|
Nov 09
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+15.82%
|
$35,000
$7.27 P/Share
|
|
Oct 21
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,700
-5.06%
|
$122,100
$33.73 P/Share
|
|
Oct 21
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,700
+4.82%
|
$22,200
$6.55 P/Share
|
|
Oct 20
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,700
-5.06%
|
$122,100
$33.71 P/Share
|
|
Oct 20
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,700
+4.82%
|
$22,200
$6.55 P/Share
|
|
Oct 19
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,800
-2.61%
|
$125,400
$33.33 P/Share
|
|
Oct 19
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+4.94%
|
$22,800
$6.55 P/Share
|
|
Oct 08
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,801
-3.36%
|
$59,433
$33.67 P/Share
|
|
Oct 08
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-5.32%
|
$124,640
$32.96 P/Share
|
|
Oct 08
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Oct 07
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,324
-2.41%
|
$42,368
$32.47 P/Share
|
|
Oct 07
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.67%
|
$128,535
$33.09 P/Share
|
|
Oct 07
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Oct 06
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-5.32%
|
$124,640
$32.27 P/Share
|
|
Oct 06
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Oct 06
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.79%
|
$160,000
$32.3 P/Share
|
|
Oct 06
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+15.82%
|
$35,000
$7.27 P/Share
|
|
Oct 05
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.79%
|
$160,000
$32.51 P/Share
|
|
Oct 05
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+15.82%
|
$35,000
$7.27 P/Share
|